225 related articles for article (PubMed ID: 9517606)
1. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
Rutgers SR; Koëter GH; van der Mark TW; Postma DS
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5'-monophosphate-induced bronchoconstriction in patients with COPD.
Rutgers SR; Koëter GH; Van Der Mark TW; Postma DS
Clin Exp Allergy; 1999 Sep; 29(9):1287-92. PubMed ID: 10469040
[TBL] [Abstract][Full Text] [Related]
3. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
4. Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma.
O'Connor BJ; Ridge SM; Barnes PJ; Fuller RW
Am Rev Respir Dis; 1992 Sep; 146(3):560-4. PubMed ID: 1519828
[TBL] [Abstract][Full Text] [Related]
5. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP.
Piccillo G; Caponnetto P; Barton S; Russo C; Origlio A; Bonaccorsi A; Di Maria A; Oliveri C; Polosa R
Respir Med; 2008 Feb; 102(2):256-65. PubMed ID: 17964770
[TBL] [Abstract][Full Text] [Related]
6. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
7. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
Spicuzza L; Scuderi V; Morjaria JB; Prosperini G; Arcidiacono G; Caruso M; Folisi C; Di Maria GU; Polosa R
Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
[TBL] [Abstract][Full Text] [Related]
8. Do patients with COPD benefit from treatment with inhaled corticosteroids?
van Schayck CP; van Grunsven PM; Dekhuijzen PN
Eur Respir J; 1996 Oct; 9(10):1969-72. PubMed ID: 8902451
[No Abstract] [Full Text] [Related]
9. The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD.
Renkema TE; Kerstjens HA; Schouten JP; Vonk JM; Koëter GH; Postma DS
Clin Exp Allergy; 1998 Oct; 28(10):1210-8. PubMed ID: 9824387
[TBL] [Abstract][Full Text] [Related]
10. Airway responsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease is determined by smoking.
Oosterhoff Y; de Jong JW; Jansen MA; Koëter GH; Postma DS
Am Rev Respir Dis; 1993 Mar; 147(3):553-8. PubMed ID: 8442586
[TBL] [Abstract][Full Text] [Related]
11. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
12. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness.
Terzano C; Petroianni A; Ricci A; D'Antoni L; Allegra L
Eur Rev Med Pharmacol Sci; 2004; 8(6):259-64. PubMed ID: 15745385
[TBL] [Abstract][Full Text] [Related]
13. Comparative cutoff points for adenosine monophosphate and methacholine challenge testing.
Fardon TC; Fardon EJ; Hodge MR; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):365-72. PubMed ID: 15521373
[TBL] [Abstract][Full Text] [Related]
14. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
[TBL] [Abstract][Full Text] [Related]
16. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
[TBL] [Abstract][Full Text] [Related]
17. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen.
Swystun VA; Bhagat R; Kalra S; Jennings B; Cockcroft DW
J Allergy Clin Immunol; 1998 Sep; 102(3):363-7. PubMed ID: 9768574
[TBL] [Abstract][Full Text] [Related]
19. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
Weersink EJ; Douma RR; Postma DS; Koëter GH
Am J Respir Crit Care Med; 1997 Apr; 155(4):1241-6. PubMed ID: 9105061
[TBL] [Abstract][Full Text] [Related]
20. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
